[Clinical testing of a new combination product of a beta blocking agent and a nitroderivative].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002082:Butylamines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D004357:Drug Synergism; D004562:Electrocardiography; D006801:Humans; D008875:Middle Aged; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D002082:Butylamines; D013565:Sympatholytics; D010417:Pentaerythritol Tetranitrate
Sperimentazione clinica di un nuovo prodotto di associazione di un farmaco beta-bloccante con un nitroderivato.